EMA Withdrawn: Trovan IV (alatrofloxacin mesilate) — Pfizer Limited

View source ↗

Summary

EU status: Trovan IV (alatrofloxacin mesilate) withdrawn from the market by Pfizer Limited as of 31/12/2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Drugs mentioned

• Trovan IV (alatrofloxacin mesilate)

Snippet

Status: Withdrawn. Therapeutic area: Bacterial Infections. MAH: Pfizer Limited. Decision date: 31/12/2009